These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6675811)

  • 1. The visual system in myelin disorders. Clinical chemistry and cytology (blood, urine, cerebrospinal fluid).
    Lowenthal A
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():233-6. PubMed ID: 6675811
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelin basic protein in cerebrospinal fluid as an indicator of active demyelination.
    Cohen SR; Herndon RM; McKhann GM
    Trans Am Neurol Assoc; 1976; 101():45-7. PubMed ID: 1028269
    [No Abstract]   [Full Text] [Related]  

  • 3. Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease.
    Gellein K; Skogholt JH; Aaseth J; Thoresen GB; Lierhagen S; Steinnes E; Syversen T; Flaten TP
    J Neurol Sci; 2008 Mar; 266(1-2):70-8. PubMed ID: 17900623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Demyelinating diseases and the cerebrospinal fluid cytoproteinogram].
    Limongi JC; Machado LR; Spina-França A
    Arq Neuropsiquiatr; 1981 Sep; 39(3):296-300. PubMed ID: 6119970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do 'demyelinating' diseases involve more than myelin?
    Waxman SG
    Nat Med; 2000 Jul; 6(7):738-9. PubMed ID: 10888913
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical usefulness of oligoclonal bands].
    Falip M; Tintoré M; Jardí R; Duran I; Link H; Montalbán X
    Rev Neurol; 2001 Jun 16-30; 32(12):1120-4. PubMed ID: 11562840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement regulator factor H in multiple sclerosis.
    Ingram G; Hakobyan S; Loveless S; Robertson N; Morgan BP
    J Cell Biochem; 2011 Oct; 112(10):2653-4. PubMed ID: 21618592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demyelinating activity of cerebrospinal fluid from multiple sclerosis patients tested in a new model system, the optic nerves of xenopus tadpoles.
    Tabira T; Webster HF; Wray SH
    Trans Am Neurol Assoc; 1975; 100():103-6. PubMed ID: 1226590
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrospinal-fluid changes in demyelinating disorders.
    N Engl J Med; 1977 Apr; 296(15):883-4. PubMed ID: 846503
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of myelin basic protein in cerebrospinal fluid.
    Ohta M; Ohta K
    Expert Rev Mol Diagn; 2002 Nov; 2(6):627-33. PubMed ID: 12465458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
    Valis M; Talab R; Stourac P; Andrys C; Masopust J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case of central nervous system damage with marked kynurenuria].
    Szulc-Kuberska J; Dudek H
    Neurol Neurochir Pol; 1974; 8(5):641-4. PubMed ID: 4427701
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid lipids in demyelinating disease. I. Sphingolipids.
    Seidel D; Buck R; Heipertz R; Pilz H
    J Neurol; 1980 Jan; 222(3):171-6. PubMed ID: 6153704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event.
    Alvarez-Lafuente R; García-Montojo M; De Las Heras V; Bartolomé M; Arroyo R
    Mult Scler; 2007 Jun; 13(5):590-5. PubMed ID: 17548437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
    Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
    Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin basic protein in multiple sclerosis and other neurological disorders.
    Kalistová H; Havrdová E; Uhrová J; Zeman D; Týblová M; Mrázová K
    J Neurol; 2003 Jul; 250(7):874-5. PubMed ID: 12883934
    [No Abstract]   [Full Text] [Related]  

  • 17. The visual system in myelin disorders. General neurological signs.
    Lowenthal A
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():125-6. PubMed ID: 6675801
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid in multiple sclerosis.
    Lowenthal A; Karcher D
    Clin Neurosci; 1994; 2(3-4):211-4. PubMed ID: 7749890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelotoxicity of serum and spinal fluid in multiple sclerosis: a critical assessment.
    Hughes D; Field EJ
    Clin Exp Immunol; 1967 May; 2(3):295-309. PubMed ID: 6035194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and cerebrospinal fluid uric acid levels in multiple sclerosis patients.
    Zamani A; Rezaei A; Khaeir F; Hooper DC
    Clin Neurol Neurosurg; 2008 Jun; 110(6):642-3. PubMed ID: 18471958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.